Co-trimoxazole for idiopathic pulmonary fibrosis: time for TIPAC-2?

[...]we suggest that there is an urgent need for a large phase III trial of co-trimoxazole therapy to be conducted in IPF.

Saved in:
Bibliographic Details
Published inThorax Vol. 68; no. 2; pp. 123 - 124
Main Authors Mujakperuo, Helen, McGrath, Emmet E, Thickett, David R
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd and British Thoracic Society 01.02.2013
BMJ Publishing Group LTD
Subjects
Anti-Infective Agents - therapeutic use
Bacterial Infection
Bacterial infections
Female
Humans
Idiopathic Pulmonary Fibrosis - drug therapy
Innate Immunity
Interstitial Fibrosis
Male
Mortality
Pneumonia
Quality of life
Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use
Online AccessGet full text

Cover

More Information
Summary:[...]we suggest that there is an urgent need for a large phase III trial of co-trimoxazole therapy to be conducted in IPF.
Bibliography:href:thoraxjnl-68-123.pdf
ArticleID:thoraxjnl-2012-202531
istex:03A6DF7117A4899297E9D0AD7858D20FF4C91AE1
Related-article-href:10.1136/thoraxjnl-2012-202403
PMID:23204064
related-article-ID:RA1
ark:/67375/NVC-BSFKR258-Z
local:thoraxjnl;68/2/123
SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0040-6376
1468-3296
DOI:10.1136/thoraxjnl-2012-202531